“Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions

The use of DES for the treatment of diffuse lesions was associated with a low rate of repeat revascularization, irrespective of stent type. No safety concerns were raised at medium-term follow-up.